The estimated Net Worth of Sudhakar V Shenoy is at least $39.3 Tysiąc dollars as of 19 April 2013. Sudhakar Shenoy owns over 105,000 units of IGC Pharma Inc stock worth over $39,323 and over the last 16 years Sudhakar sold IGC stock worth over $0.
Sign up
Sudhakar Shenoy IGC stock SEC Form 4 insiders trading
Sudhakar has made over 1 trades of the IGC Pharma Inc stock since 2013, according to the Form 4 filled with the SEC. Most recently Sudhakar bought 105,000 units of IGC stock worth $39,323 on 19 April 2013.
The largest trade Sudhakar's ever made was buying 105,000 units of IGC Pharma Inc stock on 19 April 2013 worth over $39,323. On average, Sudhakar trades about 11,667 units every 0 days since 2009. As of 19 April 2013 Sudhakar still owns at least 105,000 units of IGC Pharma Inc stock.
You can see the complete history of Sudhakar Shenoy stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
What's Sudhakar Shenoy's mailing address?
Sudhakar's mailing address filed with the SEC is PO BOX 60642, , POTOMAC, MD, 20859.
Insiders trading at IGC Pharma Inc
Over the last 17 years, insiders at IGC Pharma Inc have traded over $12,397,736 worth of IGC Pharma Inc stock and bought 1,543,722 units worth $473,972 . The most active insiders traders include Ram Mukunda, Steven Michael Oliveira oraz Zwirn & Co., L.P.Zwirn Dani.... On average, IGC Pharma Inc executives and independent directors trade stock every 143 days with the average trade being worth of $93,624. The most recent stock trade was executed by Ram Mukunda on 13 March 2024, trading 1,184,585 units of IGC stock currently worth $443,627.
What does IGC Pharma Inc do?
igc is developing a product portfolio of phytocannabinoid-based therapies through leading edge research for the treatment of a wide range of therapeutic indications. these include neuropathic and cancer pain, epilepsy, end of life supportive care, adjunctive supportive therapies of chronic neurological and oncological diagnosis, which are life altering or life threatening our mission is to treat pain, ptsd, seizures, cachexia, chronic and terminal neurological and oncological diagnoses, and other life altering conditions with phytocannabinoid-based treatments
What does IGC Pharma Inc's logo look like?
Complete history of Sudhakar Shenoy stock trades at IGC Pharma Inc
IGC Pharma Inc executives and stock owners
IGC Pharma Inc executives and other stock owners filed with the SEC include:
-
Ram Mukunda,
Exec. Chairman, Pres & CEO -
Claudia Grimaldi,
Vice President, Principal Financial Officer -
Claudia Grimaldi,
VP & Principal Financial Officer -
Richard Prins,
Independent Chairman of the Board -
Rohit Goel,
Manager and Principal Accounting Officer -
Dr. Ranga C. Krishna M.D.,
Sr. Advisor -
Parveen Mukunda,
Corp. Sec. -
Rohit Goel,
Sr. Director of Accounting & Principal Accounting Officer -
John Edward Lynch,
Director -
John Cherin,
CFO, Treasurer and PAO -
Sudhakar V Shenoy,
Director -
Ranga C Krishna,
Director -
Terry L Lierman,
Director -
Shu Kwong Ngai,
Interim CFO -
Zwirn & Co., L.P.Zwirn Dani...,
-
Acquisition Master Fund Ltd...,
10% owner -
Suhail Nathani,
Director -
Ag Ubs,
10% owner -
Steven Michael Oliveira,
10% owner -
Master Fund Ltd. Nisswa,
10% owner -
Ram Mukunda,
CEO -
Strategic Investment Fund A...,
10% owner -
James P Moran,
Director